Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Day Range2.370 - 2.450 | 52 Wk Range0.955 - 4.420 | Open / Close2.440 / - | Float / Outstanding61.365M / 76.496M |
Vol / Avg.32.023K / 186.172K | Mkt Cap186.267M | P/E- | 50d Avg. Price1.870 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.365M | EPS-1.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-13 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.340 | -0.0100 | ||||
REV | 10.170M | 11.107M | 937.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Holdings (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), ATI Physical Therapy (NYSE:ATIP) and OPKO Health (NASDAQ:OPK).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 105.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $2.435 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q4 earnings are confirmed for Monday, March 13, 2023.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.